Fibromyalgia: In support of appropriate care
- By Marc Dumoulin,
- Gérard Bergua,
- Yves Le Noc,
- Éric Drahi,
- Dragos-Paul Hagiu,
- Claude Scali
- and Élisabeth Steyer
Pages 59 to 63
Cite this article
- DUMOULIN, Marc,
- BERGUA, Gérard,
- LE NOC, Yves,
- DRAHI, Éric,
- HAGIU, Dragos-Paul,
- SCALI, Claude
- and STEYER, Élisabeth,
- Dumoulin, Marc.,
- et al.
- Dumoulin, M.,
- Bergua, G.,
- Le Noc, Y.,
- Drahi, É.,
- Hagiu, D.-P.,
- Scali, C.
- and Steyer, É.
https://doi.org/10.1684/med.2023.848
Cite this article
- Dumoulin, M.,
- Bergua, G.,
- Le Noc, Y.,
- Drahi, É.,
- Hagiu, D.-P.,
- Scali, C.
- and Steyer, É.
- Dumoulin, Marc.,
- et al.
- DUMOULIN, Marc,
- BERGUA, Gérard,
- LE NOC, Yves,
- DRAHI, Éric,
- HAGIU, Dragos-Paul,
- SCALI, Claude
- and STEYER, Élisabeth,
https://doi.org/10.1684/med.2023.848
In France, the prevalence of fibromyalgia syndrome is estimated at 1.6%, with major medical and psychosocial consequences. Its treatment is not standardized, is usually symptomatic, and is responsible for considerable medical wandering, repeated consultations and examinations, reduced quality of life, absenteeism from work, and disability. All of this generates significant direct and indirect medical costs. Long ignored, the vast majority of authors agree that this illness is real and legitimate. But many doctors say they feel helpless. Several recent publications and studies have clarified the causes, epidemiology, and diagnostic elements of this pathology, and have attempted to define a management strategy.
- fibromyalgia
- nociplastic pain
- acupuncture
- Tai Chi
- transcranial stimulation
- drug therapies
Publisher keywords: acupuncture, drug therapies, fibromyalgia, nociplastic pain, Tai-chi, transcranial stimulation